Reduction in acute myocardial infarction hospitalization after implementation of a smoking ordinance

Gerrit Bruintjes1, Becki Bucher Bartelson, Paul Hurst

  • 1Colorado School of Public Health, University of Colorado, Aurora, USA.

Insights

A public smoking ordinance in Greeley, Colorado, was linked to fewer hospitalizations for acute myocardial infarction (AMI). The reduction was most significant among smokers, challenging previous assumptions about smoke-free policy benefits.

Area of Science:

  • Public health
  • Cardiovascular epidemiology
  • Environmental health policy

Background:

  • Previous studies suggest smoking ordinances reduce acute myocardial infarction (AMI) rates, but often lack patient-level data.
  • Understanding the impact of smoking bans on AMI hospitalizations is crucial for public health policy.

Purpose of the Study:

  • To determine if a smoking ordinance reduced hospitalizations for acute myocardial infarction (AMI).
  • To assess the association irrespective of patient smoking status or infarct type (ST elevation vs. non-ST elevation).

Main Methods:

  • Utilized detailed chart abstraction of biomarkers to confirm first AMI events.
  • Analyzed data from a single community hospital serving Greeley, Colorado, and adjacent zip codes.
  • Employed Poisson regression analysis, adjusted for population growth, to assess changes in incidence rates before and after the ordinance.

Main Results:

  • A total of 706 hospitalizations for AMI were identified between July 2002 and June 2006.
  • Greeley experienced a significant reduction in AMI hospitalizations post-ordinance (RR 0.73; 95% CI, 0.59-0.90).
  • The reduction was more pronounced among smokers (RR 0.44; 95% CI, 0.29-0.65) than nonsmokers (RR 0.86; 95% CI, 0.67-1.09).

Conclusions:

  • The smoking ordinance was associated with a decrease in AMI hospitalizations, aligning with prior research.
  • The observed reductions were greatest among smokers, suggesting smoke-free policies may benefit this group directly.
  • The study highlights the potential positive impact of smoke-free policies on cardiovascular health, particularly for smokers.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...